newsfilter
← Latest News
GlobeNewswire·

Applied Molecular Transport Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Company held end of Phase 2 meeting with FDA to discuss advancing oral AMT-101 monotherapy to Phase 3 in chronic pouchitis, an orphan indication with no FDA-approved products Anticipate Phase 2 top-line readout for oral